Global Alzheimer’s Therapeutics Market Report (2022 to 2032) – Players Include Macleods Pharmaceuticals, Viatris, Lupin and Cipla – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Alzheimer’s Therapeutics Market 2022-2032” report has been added to ResearchAndMarkets.com’s offering.

This report offers a global industry analysis for 2017-2021 and an opportunity assessment for 2022-2032.

Companies Mentioned

• Abbvie, Inc.
• Teva Pharmaceuticals Ltd.
• Eisai Co. Ltd.
• Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
• Novartis AG
• Zydus Lifesciences Ltd (Cadila)
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy’s Laboratories Ltd
• Aurobindo Pharma Ltd
• Amneal Pharmaceuticals Inc.
• Macleods Pharmaceuticals Ltd.
• Viatris Inc.
• Lupin Ltd
• Cipla Ltd.
• Torrent Pharmaceuticals Ltd.
• Unichem Laboratories Ltd
• Lannett Inc.

The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the Alzheimer’s therapeutics market, the growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the Alzheimer’s therapeutics market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in this market in the coming years.

The report provides detailed information about the current and future growth prospects of the Alzheimer’s therapeutics market in the most comprehensive way for a better understanding of readers.

Key Segments of Alzheimer’s Therapeutics Market

This study on the Alzheimer’s therapeutics market offers information divided into four important segments – drug name, drug class, distribution channel and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

• Drug Name
• Donepezil
• Rivastigmine
• Memantine
• Galantamine
• Manufactured Combination of Memantine and Donepezil
• Drug Class
• Cholinesterase Inhibitors
• NMDA Receptor Antagonists
• Manufactured Combination
• Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)

Key Topics Covered:

1. Executive Summary

2. Market Overview

3. Key Market Trends

4. Key Success Factors

5. Global Alzheimer’s Therapeutics Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

5.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Market Background

6.1. Macro-Economic Factors

6.1.1. Global Healthcare Spending Overview

6.1.2. Global Pharmaceutical Market Outlook

6.1.3. Global Prevalence of Dementia

6.2. Forecast Factors – Relevance & Impact

6.2.1. Rising ageing population

6.2.2. Growing investment in healthcare expenditure

6.2.3. Growing advancements in diagnostic technologies

6.2.4. Rising prevalence of neurodegenerative disease

6.2.5. Adverse effects may impact the market growth

6.2.6. Key Strategic Developments

6.2.7. Product Adoption Rate and Demand

6.2.8. New Product Launches

6.3. COVID-19 Crisis – Impact Assessment

6.4. Market Dynamics

6.4.1. Drivers

6.4.2. Restraints

6.4.3. Opportunity Analysis

6.5. Global Supply Demand Analysis

7. Global Alzheimer’s Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Name

8. Global Alzheimer’s Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Class

9. Global Alzheimer’s Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

10. Global Alzheimer’s Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032, by Region

11. North America Alzheimer’s Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032

12. Latin America Alzheimer’s Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032

13. Europe Alzheimer’s Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032

14. East Asia Alzheimer’s Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032

15. South Asia Alzheimer’s Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032

16. Oceania Alzheimer’s Therapeutics Market 2017-2021 and Forecast 2022-2032

17. Middle East and Africa (MEA) Alzheimer’s Therapeutics Market Analysis 2017-2021 and Forecast 2022-2032

18. Market Structure Analysis

18.1. Market Analysis, By Tier of Companies

18.2. Market Share Analysis of Top Players

18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard

19.2. Key Development Analysis

19.3. Competition Benchmarking

19.4. Competition Deep Dive

20. Assumptions and Acronyms Used

21. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/3pg6vy

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900